EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025

Canada T L Cherry iD, Helen M Evans iD, Stephen W Mouat, Jonathan R Bishop, Amin J Roberts, Nir Fireman, Ashwin Bhana, Jillian J Haszard, Andrew S Day iD, Robert N Lopez iD

Crohn’s & Colitis 360 · 05.10.2026 · 8 (4)

DOI: 10.1093/crocol/otag117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crohn’s & Colitis 360, online erschienen am 28.10.2026. Verfasst von Canada T L Cherry und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Starship Hospital, Starship Child Health, Auckland, New Zealand. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Starship Foundation Clinical Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The incidence of inflammatory bowel disease (IBD) in children is increasing worldwide, with high rates previously noted in New Zealand. The incidence and prevalence of pediatric IBD in New Zealand was last delineated in 2015. The aim of this study was to provide updated epidemiological data by delineating the incidence and prevalence of pediatric IBD in New Zealand ten years after the previous assessment.

Methods

For the incidence cohort, patients younger than 16 years with IBD, diagnosed between January 1, 2025 and December 31, 2025 were identified and information entered into a secure database. Population data were obtained and incidence calculated. To derive the point prevalence, all patients diagnosed with IBD under the age of 16 years on June 30, 2025 were identified and information entered into a secure database. Population data were obtained and prevalence calculated.

Results

The incidence of pediatric IBD, Crohn’s disease (CD), ulcerative colitis (UC) and inflammatory bowel disease-unclassified (IBD-U) in New Zealand in 2025 was 8.0, 5.6, 2.0, and 0.4 per 100 000 respectively. The point prevalence of IBD, CD, UC, and IBD-U in children in New Zealand on June 30, 2025 was 33.0, 21.7, 8.1, and 3.2 per 100 000 respectively.

Conclusions

The incidence and prevalence of IBD have increased 1.5 times in children in New Zealand since 2015. New Zealand continues to have some of the highest rates of pediatric IBD in the world. Ongoing research is needed to understand factors leading to increasing rates and to ensure appropriate health service provision.

Schlagwörter

Stichwörter der Autor:innen

IBDepidemiologypediatrics

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology, Starship Hospital, Starship Child Health, Auckland, New Zealand.
  • Paediatric Gastroenterology, Tiny Giants Paediatric Specialists, Auckland, New Zealand.
  • Department of Paediatrics, Capital, Coast and Hutt Valley, New Zealand.
  • Department of Paediatrics, Christchurch Hospital, Christchurch, New Zealand.

ORCID-Profile: Canada T L Cherry, Helen M Evans, Andrew S Day, Robert N Lopez

Förderung

  • Starship Foundation Clinical Research Grant

Zitieren

APA

Cherry, C. T. L., Evans, H. M., Mouat, S. W., Bishop, J. R., Roberts, A. J., Fireman, N., Bhana, A., Haszard, J. J., Day, A. S., & Lopez, R. N. (2026). Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025. Crohn’s & Colitis 360, 8(4). https://doi.org/10.1093/crocol/otag117

Vancouver

Cherry CTL, Evans HM, Mouat SW, Bishop JR, Roberts AJ, Fireman N, et al. Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025. Crohn’s & Colitis 360. 2026;8(4). doi:10.1093/crocol/otag117

BibTeX
@article{Cherry2026,
  author = {Cherry, Canada T L and Evans, Helen M and Mouat, Stephen W and Bishop, Jonathan R and Roberts, Amin J and Fireman, Nir and Bhana, Ashwin and Haszard, Jillian J and Day, Andrew S and Lopez, Robert N},
  title = {Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025},
  journal = {Crohn’s & Colitis 360},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.1093/crocol/otag117}
}
Kostenlos starten →